Related Experiment Video
Updated: Sep 17, 2025
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
7.5K
Chemotherapy-associated nephrotoxicity: a persistent clinical challenge
1Nephrology Unit, Hospital General de Niños Ricardo Gutiérrez, Autonomous City of Buenos Aires, Argentina.
Archivos Argentinos De Pediatria
|July 1, 2025
Summary
Chemotherapy can cause kidney damage (nephrotoxicity), necessitating early detection of risk factors and proactive renal prevention strategies. Close clinical monitoring is vital for managing cancer patients undergoing these treatments.
Area of Science:
- Nephrology
- Oncology
- Pharmacology
Background:
- Increasing consultations for chemotherapy-induced kidney damage observed.
- Chemotherapy improves cancer survival but poses risks to renal function.
- Need for early identification of predisposing nephrotoxic factors.
Purpose of the Study:
- To highlight the rising incidence of chemotherapy-related renal damage.
- To emphasize the importance of early detection and prevention of kidney injury in cancer patients.
Main Methods:
- Retrospective analysis of consultations at a hospital's Nephrology Unit.
- Identification of risk factors for chemotherapy-induced nephrotoxicity.
Main Results:
- Observed increase in consultations for renal damage linked to chemotherapy.
- Identified risk factors include pre-existing renal conditions, tumor infiltration, toxic metabolites, and drug accumulation.
Conclusions:
- Early detection of nephrotoxic factors is crucial for kidney protection.
- Implementation of renal prevention measures, dose adherence, and strict monitoring are essential during chemotherapy.
More Related Videos
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265
01:24Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
01:18Chronic Kidney Disease IV: Nursing Management
60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
01:11Renal Failure: Dose Adjustments
166
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
166
01:28Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82